Posts Tagged ‘FDA’


7 things YOU can and SHOULD do to stop the spread of antibiotic resistant superbugs

By | Leave a Comment

 The time may come when penicillin can be bought by anyone in the shops. Then there is the danger that the ignorant man may easily underdose himself and by exposing his microbes to non-lethal quantities of the drug make them resistant. Here is a hypothetical illustration. Mr. X. has a sore throat. He buys some […]

Read More

Posted in FDA, Global Health, WHO; Tagged: , , , , .


Hey, Hey, FDA! What do we want? Better Sunscreen! When do we want it? Now!

By | Leave a Comment

5 Facts on Skin Cancer, Sunscreen and U.S. Pharmaceutical Policy On my walk to the O’Neill Institute yesterday, I was stopped by a group of L’Oréal representatives handing out free samples of their latest sunscreen products along with information on the PASS Coalition, a lobbying effort on the part of cosmetic manufacturers and other consumer […]

Read More

Posted in FDA; Tagged: , , , , , .


A nutritionist named Coca-Cola

By | Leave a Comment

This week, the Supreme Court heard arguments in a case brought by POM Wonderful  gainst Coca-Cola, alleging fraudulent and deceptive advertising of Coca-Cola’s Pomegranate-Blueberry juice. The legal question centered on whether a private party can bring a lawsuit for misleading advertising if a label is compliant with regulations established by a federal agency, here the […]

Read More

Posted in FDA, Global Health, National Healthcare, Resources; Tagged: , , , , , .


US FDA Commissioner Margaret Hamburg to Keynote O’Neill Institute Summer Program on Emerging Issues in Food and Drug Law

By | Leave a Comment

The Commissioner of the United States Food and Drug Administration, Margaret Hamburg will provide the keynote address to the O’Neill Institute for National and Global Health Law’s Summer Program on Emerging Issues in Food and Drug Law. Margaret A. Hamburg became the 21st commissioner of food and drugs on May 18, 2009. The second woman […]

Read More

Posted in FDA, Global Health, National Healthcare, Tobacco, Trade, Uncategorized; Tagged: , , , , , .


July 14-18 – Emerging Issues in Food and Drug Law (O’Neill Institute Summer Program with Confirmed Speakers)

By | Leave a Comment

Please join the O’Neill Institute for National and Global Health Law at Georgetown University for a one-week intensive summer institute exploring the domestic and international legal, regulatory, and policy framework shaping the safety and availability of foods and medicines worldwide. The program will cover U.S. domestic law including recent laws and regulations; international regulatory harmonization […]

Read More

Posted in FDA, Global Health, Health reform, National Healthcare, Tobacco, Trade, Uncategorized; Tagged: , , , , .


Lasting harm from Hepatitis B vaccination scare in China

By | Leave a Comment

A recent major concern about the safety of Hepatitis B vaccines in China has put manufacturers and the health authorities under a spotlight and threatened progress in significantly lowering Hep B infection rate two decades after China added the Hep B vaccine into the newborn immunization plan in 1992. Last month, Chinese media relayed suspicions […]

Read More

Posted in Global Health; Tagged: , , , , .


Good Riddance to U.S. Trans Fats

By | Leave a Comment

The Food and Drug Administration (FDA) has been subject to frequent criticism for its lax oversight of food safety, and particularly of food additives. However, this morning the agency stepped out ahead of most of its international peers, submitting for public comment a new determination that would effectively remove partially hydrogenated oils (PHOs), the primary […]

Read More

Posted in FDA; Tagged: , , , , .


The Breast Milk Market and the Need for Clearer Rules

By | Leave a Comment

    Source: CDC A study published in Pediatrics by researchers at Nationwide Children’s Hospital in Columbus, OH has been in the news (ABC News; Wall Street Journal; New York Times) after they found that 72% of the breast milk samples they purchased online contained infection-causing bacteria. This comes after increased awareness and promotion of […]

Read More

Posted in FDA; Tagged: , , , , .


Will FDA Turn the Tide on Industry-wide Medical Product Development?

By | Leave a Comment

The advent of big data has forced a sea change throughout the scientific research enterprise, shaking the industry’s fundamental attitude towards the data themselves. Data is now understood as the currency of research. Consequently, industry is warming to the new reality that legal norms once considered to drive business – confidential commercial information, trade secrets […]

Read More

Posted in FDA, Health reform, National Healthcare, Updates; Tagged: , , , .


Industry Trumps Evidence in Tobacco Packaging U-Turn

By | Leave a Comment

This post was written by Holly Jarman, Research Assistant Professor at the University of Michigan.  For more information about this post, please contact hjarman@umich.edu. The original post can be found at the Huffington Post. The government’s disappointing U-turn over plain packaging of tobacco has dealt a blow to campaigners and shows a government attempting to […]

Read More

Posted in Uncategorized; Tagged: , , , , , , , , , , , .


Browse by Category

Browse by Month

2014

October (10), September (7), August (5), July (8), June (12), May (10), April (12), March (11), February (12), January (7)

2013

December (8), November (8), October (15), September (5), August (4), July (8), June (13), May (10), April (8), March (9), February (8), January (3)

2012

December (3), November (3), October (2), August (1), July (6), June (2), May (3), April (3), March (2), February (2), January (4)

2011

December (2), November (2), October (4), September (3), August (5), July (5), June (9)

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.